Abstract
Introduction: The global impact of Coronavirus Disease 2019 (COVID-19), caused by severe-acute-respiratory-syndrome coronavirus 2 (SARS-CoV-2), has been profound, claiming the lives of more than 3 million individuals within a year and a half. Among the affected population, heightened vulnerability is observed among older and frailer individuals, leading to more severe symptoms and adverse outcomes compared to their younger, non-frail counterparts. This study to analyze the impact of frailty on the outcomes of adult patients admitted with COVID-19.
Methods: Using the National Inpatient Sample (NIS) database 2020, we identified adult patients admitted with a principal diagnosis of COVID-19. The patients were then divided into two groups, i.e., frail and non-frail, based on the Hospital Frailty Risk Score (HFRS) cut-off of 5. Using a multivariate regression model, we compared COVID-19 hospitalizations, with frailty status serving as the exposure variable. Statistical analysis was performed using STATA version 14.2.
Results: Out of 1,050,045 adult patients hospitalized with COVID-19, 509,915 (48.56%) met the criteria for frailty. Among these frail patients, the majority were white, older females with a high comorbidity burden. Compared to their non-frail counterparts, these frail patients experienced greater odds of mortality (adjusted odds ratio [aOR] 4.00, 95% confidence interval [CI] 3.78–4.23;P.
Conclusion: In conclusion, our findings highlight a complex interplay between COVID-19 and frailty, revealing that frailty is associated with increased odds of mortality as well as associated complications. These findings contribute to a deeper understanding of the clinical complexities surrounding COVID-19 in frail patients, necessitating tailored management strategies.
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Recommended Citation
Jaan A, Shah P, Dhawan A, Qaiser S, Ali A, Thwe H, Abimbolu O, Okpara C, Rajnik M. Impact of Frailty on Inpatient Outcomes of COVID-19 Patients: Evidence From a US National Inpatient Sample. Advances in Clinical Medical Research and Healthcare Delivery. 2025; 5(4):22-32. doi: 10.53785/2769-2779.1268.